The CDPP provides a wide range of services to government agencies, the pharmaceutical industry, professional organizations, and private businesses.

Credible Research and Consultation

Connecting key variables and establishing causal relationships in our research...connecting science and marketing our consulting...connecting presentation of results with major decision makers at our conferences...these are the strengths of the Center on Drugs and Public Policy (CDPP). At CDPP, we research the links between medication use and outcomes within the context of public health, public policy, and disease management.

How are patient data collected? How are they reported? How do regulatory agencies and managed care interpret these data? How do they apply their inferences to health care? How does this affect the development of public health policy? How does this affect public and private insurance programs? How does this affect overall public health? How does this influence drug development?

These types of questions form the basis for our research related to:

  • Health care policy
  • Health care organization and finance studies
  • Pharmacoeconomics and outcomes research
  • Pharmacoepidemiology
  • Drug law and regulation
  • Drug use studies
  • Health services research
  • International pharmaceutical policy

Our faculty members, widely published in refereed journals, explore topics ranging from managed care provision and pharmacoeconomics to the legal and regulatory environment affecting drug development. Our expertise translate into perceptive and reasoned analytical solutions for your organization. We can design, develop and carry out an entire research initiative to meet your specific needs, or handle any portion in collaboration with your staff. The CDPP provides consultative services on all facets of drug use and public policy. We are familiar with the current approaches and problems so we can offer innovative alternative solutions and applications.

The CDPP developed screening criteria for State Drug Utilization Review (DUR) Boards, in compliance with OBRA-90. These criteria have served as a national model. We have also conducted retrospective analyses of drug use and evaluations of interventions to improve drug use for a number of targeted disease states including asthma, hearth disease, diabetes, cancer, and infectious diseases.

Unbiased Educational Programming

CDPP educational programming not only connects our research to public health issues, but also offers a forum for others to explore current trends in health care practice. We focus on topics such as the ramifications of health care legislation and changes in the health care system. As an educational group located in the Department of Pharmacy Practice and Science, our goal it to bring together health care providers, payors, government officials, that pharmaceutical industry, and academics for open discussion and debate of the public health issues in the regulatory arena. Our biannual invitational Wintergreen Conference highlights cutting edge research by pharmacy school faculty and graduate students and had served as a springboard to major research projects.

In conducting professional scientific conferences, we handle all of the logistical matters from site selection and promotion, to program development and speaker selection, to the publication of official proceedings. For example, the CDPP organized the National Symposium on Oral Counseling by Pharmacist About Prescription Medicines and the Medical and Economic Influences Impacting Breast Cancer in High-Risk Women. For the latter conference, proceedings were published in The American Journal of Managed Care.